A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, +27

Nature Medicine

Viral DiagnosticsDiagnostic TestSerologic TestingMolecular DiagnosticsSerological Assay +1

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg, Fatima Amanat, Adolfo Firpo, +15

Science

SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup

Daniel Stadlbauer, Fatima Amanat, Veronika Chromikova, +13

Current Protocols in Microbiology

Viral DiagnosticsImmunodeficienciesImmunologyViral PathogenesisImmunodominance +16

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, +31

Immunity

VaccinationNanomedicineCross-protectionMucosal VaccinationVaccine Development +9

A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, +27

A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice

Dorottya Laczkó, Michael J. Hogan, Sushila A. Toulmin, +39

Immunity

VaccinationHumoral Immune ResponsesVaccine DevelopmentVaccine TargetImmunology +6

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Raffael Nachbagauer, Jodi Feser, Abdollah Naficy, +30

Nature Medicine

VaccinationCross-protectionVaccine DevelopmentVaccine TargetImmunology +8

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Fatima Amanat, Mahima Thapa, Tinting Lei, +14

Cell

VaccinationDiverse AntibodiesVaccine DevelopmentVaccine TargetImmunology +4

Human germinal centres engage memory and naive B cells after influenza vaccination

Jackson S. Turner, Julian Q. Zhou, Julianna Han, +20

Nature

VaccinationNaive B CellsPathogenesisImmunologyHumoral Response +8

Broadly protective human antibodies that target the active site of influenza virus neuraminidase

Daniel Stadlbauer, Xueyong Zhu, Meagan McMahon, +10

Science